危重症相关性皮质醇不足的诊治研究进展  

The diagnosis and treatment of critical illness-related corticosteroid insufficiency

作　　者：张哲哲（综述）[1] 钱素云（审校）[1] 

机构地区：[1]首都医科大学附属北京儿童医院急救中心,100045

出　　处：《中国小儿急救医学》2011年第5期460-462,共3页Chinese Pediatric Emergency Medicine

摘　　要：近年来，危重症患者合并的“肾上腺相对功能不全”已成为研究热点，随着研究进展，学者们认为该定义不够准确。因此提出了危重症相关性皮质醇不足（critical illness—related corticosteroid insufficiency，CIRCI）这一概念。CIRCI目前尚无统一诊断标准，其对危重症患者激素治疗的指导作用也不甚明确。本文仅就目前CIRCI诊断以及激素替代治疗的现状进行综述。In recent years, relative adrenal insufficiency in critical patients has become a hot issue. With progression of studies, this definition is insufficient in accuracy. Thus a new definition of critical illness- related corticosteroid insufficiency （CIRCI） is developed. Now CIRCI have not had consentaneous diagnostic criteria. Moreover, the benefits of this diagnose to corticosteroid treatment in critical patients remains unclear. This article will review on the diagnosis of CIRCI and current situation of corticosteroid treatment.

关 键 词：危重症相关性皮质醇不足 脓毒症 脓毒性休克 糖皮质激素 

分 类 号：R473.5[医药卫生—护理学]